Objectives: To describe the impact on EOGBS rates following reversion from screening-7 based to risk-based IAP for prevention. 
In a previous paper published in this journal we reported that despite of a risk based 7 approach, EOGBS rates in our north west London hospital had remained consistently 
Methods:
4 Design: Non-randomized observational study compared to historical controls. 
12
Primary outcome: The EOGBS rate (per 1000 live births) in the study period was 13 compared to rates in historical controls with specific reference to the approach used for 14 targeting administration of intrapartum prophylaxis for prevention of EOGBS. was given in labour in accordance with local guidelines.
10
A vertical audit of randomly selected antepartum and intrapartum records of 60 women
11
(approximately 1.2% of women) was performed to assess overall compliance with the 12 local guidelines.
13
Statistics:
14
As our intervention was a service improvement initiative rather than a research study,
15
we did not perform a statistical sample size calculation to determine the 16 number of the mothers who needed to be included to demonstrate a statistical 17 difference in invasive EOGBS rates. Rather all women (total population) 18 during the study period were aimed to be included. We compared the characteristics of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  p  e  e  r  r  e  v  i  e  w  o  n  l  y   9 Differences in EOGBS infection rates between pre-screening, screening and post-1 screening time periods, were analysed using regression methods. An 'unadjusted' 2 analysis was performed and subsequently an analysis adjusted for patient ethnicity.
3
Individual patient data was not available for all time periods, and thus it was not possible 4 to adjust for all patient demographics. The regression analysis was performed using
5
Poisson regression. The difference in EOGBS occurrence between time periods is 6 expressed as a ratio, along with confidence interval for both the unadjusted and 7 adjusted analyses. Significance level was set at p <0.05.
8
Women with missing demographic data were excluded from analysis.
9
Ethics: No ethical approval was necessary as this study was a service evaluation and 10 audit of compliance with recommended national guidance.
11

Results
12
Gestational ages of the newborn, mode of delivery and demographic characteristics of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 demographics of the women. Changes to gestational age were slight.
5
The largest noticeable differences were changes in ethnicity. There was an increase in 6 the percentage in the 'white other' group from 20% to reach 31% in the post-screening 7 period, and a reduction in black women (14% down to 8%) in the same period. The 8 proportion of white British/Irish women also showed a drop from 11% to 8% between 9 the pre-screening and post-screening periods. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 One of the term babies died of severe septicaemia secondary to the EOGBS infection.
3
Horizontal audit (Table 2) showed that only one of the nine mothers whose babies 4 developed EOGBS had a recognized risk factor. GBS was detected in vaginal swab 5 taken for investigation of discharge during an antenatal visit, but she was not given IAP 6 due to failure to act on the antenatal laboratory result. Another mother developed post- antenatally and another mother had intrapartum pyrexia of >38º C. All three mothers were given IAP according to local and national guidelines. Table 3 11 EOGBS rates in the pre-screening, screening and post-screening periods. 
15
The ethnicity adjusted analyses gave broadly similar results to the unadjusted analyses.
16
Discussion:
17 This recommendation is in part due to the possible adverse effects of exposing a large 11 number of women to antibiotics in a screening based approach compared to risk based 12 approach. However, the horizontal audit in our study suggests that the potential for a 13 risk-based approach to be effective in our population is limited as only one of the nine 14 mothers of babies with EOGBS had a recognized risk factor. Unfortunately, she was not
15
given IAP due to failure to act on GBS detected in a vaginal swab taken antenatally. who have received penicillin-based IAP.
12
In conclusion, the findings of this observational study provide further evidence of the 13 efficacy of screening based IAP compared to risk based IAP in prevention of EOGBS in 14 newborns in an area of high incidence. We believe that in such a setting the benefit is 15 likely to outweigh any potential risks to the mother or baby. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 screening, screening and post-screening).
15
▪ As our results are based on an observational rather than experimental study design,
16
our findings might be explained by factors other than the prevention approach.
17
▪ As a single centre study, our findings may not be generalizable to other units. when SBIAP IAP was implemented (screening period).
19
9
Primary outcome: The EOGBS rate (per 1000 live births) in the study period was 10 compared to rates in historical controls with specific reference to the approach used for 11 targeting administration of intrapartum prophylaxis for prevention of EOGBS. 
20
Identification and assessment of newborns with EOGBS and audits: Women with missing demographic data were excluded from analysis.
5
Ethics: No ethical approval was necessary as this study was a service evaluation and 6 audit of compliance with recommended national guidance.
7
Results
8
Gestational ages of the newborn, mode of delivery and demographic characteristics of 9 the women in the pre-screening, screening and post-screening periods are presented in 10 demographics of the women. Changes to gestational age were slight.
5
The largest noticeable differences were changes in ethnicity. There was an increase in Table 2. 14 Table 2 15
Maternal and neonatal characteristics in post-screening EOGBS cases One of the term babies died of severe septicaemia secondary to the EOGBS infection.
3
Horizontal audit (Table 2) showed that only one of the nine mothers whose babies 4 developed EOGBS had a recognized risk factor. GBS was detected in vaginal swab 5 taken for investigation of discharge during an antenatal visit, but she was not given IAP 6 due to failure to act on the antenatal laboratory result. Another mother developed post- 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 metronidazole which was changed to benzyl penicillin following isolation of GBS in 3 blood culture. The mother made an uneventful recovery.
4
Vertical audit showed that that three of the 60 mothers assessed had risk factors. One 5 of the mothers had antenatal GBS bacteriuria, one had GBS in a vaginal swab taken 6 antenatally and another mother had intrapartum pyrexia of >38º C. All three mothers 7 were given IAP according to local and national guidelines.
8
EOGBS rates in the pre-screening, screening and post-screening time periods are 9 shown in Table 3 and Figure 1 .
10 Table 3 11 EOGBS rates in the pre-screening, screening and post-screening periods. The rates were compared, with and without an adjustment for ethnicity. A summary of 14 the results is given in Table 4 , which shows comparisons between each pair of time 15 periods.
16 Table 4 17
Risk of EOGBS in pre-screening, screening and post-screening periods with and 18 without adjustment for ethnicity 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
15
16
We were not aware of any women developing adverse reactions to IAP through our 17 hospital's adverse event reporting system (Datix) or through departmental reporting 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 In this study, we have described the incidence of EOGBS infection in our maternity 4 services when we reverted to nationally recommended RBIAP approach for 5 administration of IAP to prevent EOGBS infection in newborns after using a SBIAP 6 approach for nearly two years. We have used this unique opportunity to compare 7 temporal associations between EOGBS rates and the two approaches in three time 8 periods (pre-screening, screening and post-screening). To the best of our knowledge 9 there are no published reports examining such an association.
10
This study shows that after adjustment for differences in ethnicity of mothers, there was 11 a five-fold increase in EOGBS rate in the post-screening period compared to the 12 screening period.
13
We noted in our study small trends in gestational age of the newborns, age of the 14 mothers and cesarean section rates over the three time periods. Whilst these changes newborns in an area of high incidence. We believe that in such a setting the benefit is 17 likely to outweigh any potential risks to the mother or baby.
18
Limitations
19
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